Stuart A. Lipton
Affiliations: | Scripps Research Institute, La Jolla, La Jolla, CA, United States | ||
| Neurosciences | University of California, San Diego, La Jolla, CA |
Area:
Neurodegenerative DiseaseWebsite:
https://www.scripps.edu/research/faculty/liptonGoogle:
"Stuart Lipton"Bio:
https://www.scripps.edu/lipton/members.html
Mean distance: 12.18 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| John E. Dowling | grad student | 1977 | Harvard |
| Torsten Wiesel | post-doc | Harvard Medical School |
Children
Sign in to add trainee| Jeffrey D. Zaremba | research assistant | 2007-2011 | Burnham Institute |
| Scott D. Ryan | post-doc | 2011- | Sanford Burnham Research Institute |
| Karthik Bodhinathan | post-doc | 2014- | Sanford-Burnham Medical Research Institute |
| Swagata Ghatak | post-doc | 2016- | |
| Elias Aizenman | post-doc | 1985-1987 | Harvard Medical School |
| Thomas Goetz | post-doc | 2000-2003 | Burnham Institute |
| Walid V. Soussou | post-doc | 2006-2008 | Burnham Institute for Medical Research |
| Juan Pina-Crespo | research scientist | 2008-2015 | Sanford Burnham Institute |
Collaborators
Sign in to add collaborator| Michael M. Segal | collaborator | 1995-2002 | Children's Hospital and Harvard Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Okamoto SI, Prikhodko O, Pina-Crespo J, et al. (2019) NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model. Neurobiology of Disease |
| Oh CK, Sultan A, Platzer J, et al. (2017) S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models. Cell Reports. 21: 2171-2182 |
| Tu S, Akhtar MW, Escorihuela RM, et al. (2017) NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism. Nature Communications. 8: 1488 |
| Nagar S, Trudler D, McKercher SR, et al. (2017) Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency. Investigative Ophthalmology & Visual Science. 58: 3741-3749 |
| Nagar S, Noveral SM, Trudler D, et al. (2017) MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress. Proceedings of the National Academy of Sciences of the United States of America |
| Lipton SA, Rezaie T, Nutter A, et al. (2016) Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models. Cell Death & Disease. 7: e2499 |
| Sunico CR, Sultan A, Nakamura T, et al. (2016) Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons. Proceedings of the National Academy of Sciences of the United States of America |
| Singec I, Crain AM, Hou J, et al. (2016) Quantitative Analysis of Human Pluripotency and Neural Specification by In-Depth (Phospho)Proteomic Profiling. Stem Cell Reports |
| Sanz-Blasco S, Piña-Crespo JC, Zhang X, et al. (2016) Levetiracetam inhibits oligomeric Aβ-induced glutamate release from human astrocytes. Neuroreport |
| Lipton SA, Nordstedt C. (2016) Partnering with Big Pharma-What Academics Need to Know. Cell. 165: 512-5 |